CTOs on the Move

Cerevel

www.cerevel.com

 
Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinson`s, Alzheimer`s, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.cerevel.com
  • 222 Jacobs Street Suite 200
    Cambridge, MA USA 02141
  • Phone: 844.304.2048

Executives

Name Title Contact Details

Funding

Cerevel raised $125M on 04/13/2021
Cerevel raised $350M on 07/01/2021

Similar Companies

AlphaRx

AlphaRx, Inc. is a Markham, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Teva Women's Health

Teva Women's Health is a Woodcliff Lake, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wraser Pharmaceuticals

Wraser Pharmaceuticals is a Ridgeland, MS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Catalyst Pharmaceuticals

Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), infantile spasms, and Tourette`s Disorder.

Embecta

Embecta will be the name of the independent, publicly-traded company that will hold BD`s Diabetes Care business